Metabolic syndrome and carotid intima-media thickness in chronic obstructive pulmonary disease

Background

The aim of this study is to investigate the prevalence of metabolic syndrome (MetS), carotid intima media thickness (IMT), and serum C-reactive protein (CRP) levels in patients with chronic obstructive pulmonary disease (COPD), and the possible relationships among them.

Methods

Fifty stable COPD patients and 40 healthy controls were included in the study. The participants were further divided into four groups according to their smoking status. Pulmonary function tests were performed in COPD patients. Anthropometric measurements and blood chemistry analysis, serum CRP levels and carotid intima-media thickness (IMT) measurements were performed in all the study population.

Results

Prevalence of metabolic syndrome was 43% in COPD patients and 30% in the control group (p?=?0.173). FEV₁% and FEV₁/FVC were higher in COPD patients with MetS (p?=?0.001 and p?=?0.014, respectively) compared to those without MetS. Prevalence of MetS was significantly different among the COPD patients with different stages (p?=?0.017) with the highest value in stage 2 (59%). Carotid IMT was significantly higher in COPD patients than in control group (1.07?±?0.25 mm and 0.86?±?0.18 mm, respectively; p?

Conclusions

Early markers of atherogenesis, in terms of carotid IMT, were found to be higher in COPD patients than in healthy controls. MetS prevalence was observed to decrease as the severity of airflow obstruction increased. Therefore, screening COPD patients for these cardiovascular risk factors would be a novel approach even in absence of symptoms.